Abstract:Genome-wide association studies (GWASs) have identified dozens of susceptibility loci for sporadic Alzheimer's disease (AD) primarily in Caucasians, but whether the same or different variants account for genetic risks in Chinese remains unknown. A two-stage case-control GWAS was conducted for subjects from 39 hospitals across China. In the discovery stage, 993 AD cases and 6,451 controls passed quality control after genotyping using Illumina HumanOmniZhongHua-8 BeadChips. In the replication stage, 55 top single nucleotide polymorphisms (SNPs) with evidence of associations and eight SNPs previously reported in Caucasians were selected for genotyping using ABI PRISM® SNaPshot™ Multiplex System in an independent cohort of 1,201 AD cases and 4,889 controls. In the combined analysis, seven SNPs had associations exceeding the genome-wide significance threshold (P < 5.0 × 10−8) with no heterogeneity between stages. The overall variance was calculated using the restricted maximum-likelihood method. HaploReg, cis-expression quantitative trait loci (cis-eQTL) database, the Gene Expression Omnibus (GEO) profiles, STRING, and the Gene Ontology enrichment analysis was used to further characterize these seven variants. For the APOE region, multifactor regression analysis using imputed data was performed. Four novel variants were identified with genome-wide significance (P < 5 × 10-8): rs463717 (5q31.3, Pcombined = 8.56 × 10-15), rs11625699 (14q13.1, Pcombined = 4.80 × 10-20), rs3784616 (15q21.1, Pcombined = 2.34 × 10-25), and rs16980322 (19q13.32, Pcombined = 2.75 × 10-21). Additionally, APOE rs405509 (Pcombined = 9.53 × 10-28), PVRL2 rs4803766 (Pcombined = 1.91 × 10-18), and PVRL2 rs387976 (Pcombined = 9.90 × 10-11) were associated with AD. These seven variants explained 15.87% of the overall variance in disease risk. For the eight previously reported SNPs selected for detection in the replication stage, only rs2070045 of SORL1 showed significant associations. Multifactor regression analysis using imputed data in APOE region found previously reported AD-associated SNPs in Caucasians remained significant in Chinese. The present GWAS identified four novel susceptibility variants for AD. The genes located near the four novel variants are functionally related to neurogenesis, suggesting neurogenesis in AD pathogenesis. This study also suggests genetic heterogeneity of AD susceptibility in Chinese and Caucasian populations. Regional association plots. Association results are shown for the analyzed SNPs with recombination rates in the four loci associated with genome-wide significance at 5q31.3 (a), 14q13.1 (b), 15q21.1 (c) and 19q13.32 (d-e). Purple diamonds represent the most significantly associated SNP in the combined analysis. The quantile-quantile (Q-Q) plot of the association results from the discovery stage analysis (993 AD cases and 6,451 controls). Displayed are observed versus expected -log10 P values for all variants. The yellow line indicates the expected distribution of - log10 P values under the null hypothesis. The plot in purple is for SNPs excluding previously reported SNPs with P > 10-12 (λGC = 1.038).

Identification of novel associations of candidate loci with Alzheimer's disease by leveraging the shared genetic basis with hippocampal volume

FOUR NOVEL SUSCEPTIBILITY VARIANTS IDENTIFIED IN CHINESE ARE ASSOCIATED WITH SPORADIC ALZHEIMER’S DISEASE

Identifying Shared Diagnostic Genes and Mechanisms in Vascular Dementia and Alzheimer's Disease Via Bioinformatics and Machine Learning

Hippocampal Transcriptome-Wide Association Study and Neurobiological Pathway Analysis for Alzheimer's Disease.

Hippocampal transcriptome-wide association study and neurobiological pathway analysis for Alzheimer’s disease

Identification of novel risk genes for Alzheimer's disease by integrating genetics from hippocampus

Genetic Architecture of Hippocampus Subfields Volumes in Alzheimer’s Disease

GWAS-Linked Loci and Neuroimaging Measures in Alzheimer’s Disease

The complex genetic architecture of Alzheimer's disease: novel insights and future directions

Genome-wide Association Study of Hippocampal Atrophy Rate in Non-Demented Elders

Identification of novel hub genes for Alzheimer's disease associated with the hippocampus using WGCNA and differential gene analysis

Novel Genomic Loci Shape Two Neuroanatomical Dimensions of AD in Non‐demented Populations

Genome-Wide Association Analysis across Endophenotypes in Alzheimer's Disease: Main Effects and Disease Stage-Specific Interactions

Brain-wide Genome-Wide Colocalization Study for Integrating Genetics, Transcriptomics and Brain Morphometry in Alzheimer's Disease

GWAS of multiple neuropathology endophenotypes identifies new risk loci and provides insights into the genetic risk of dementia

Comprehensive Analysis of Shared Genetic Loci Between Hippocampal Volume and Schizophrenia.

Multivariate GWAS of Alzheimer's disease CSF biomarker profiles implies GRIN2D in synaptic functioning

Identification of 16 novel Alzheimer's disease susceptibility loci using multi-ancestry meta-analyses of clinical Alzheimer's disease and AD-by-proxy cases from four whole genome sequencing datasets

Novel loci for Alzheimer's disease identified by a genome-wide association study in Ashkenazi Jews

Multivariate genome wide association and network analysis of subcortical imaging phenotypes in Alzheimer's disease

Identification of novel drug targets for Alzheimer’s disease by integrating genetics and proteomes from brain and blood